We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A University of Iowa study raises questions about the four-point-six billion dollars spent every year nationwide on certain types of devices for heart patients.
diaDexus today announced that new data published in the American Heart Association's journal Arteriosclerosis, Thrombosis, and Vascular Biology showed that coronary heart disease (CHD) patients with the highest levels of the enzyme Lp-PLA2 were more than twice as likely to have a recurrent cardiovascular event, whereas 95% of the patients with the lowest levels of the enzyme remained event-free over four years of follow up.
Competitive Technologies, Inc. said Thursday that the U.S. Supreme Court ruled in favor of Metabolite Laboratories, Inc. and Competitive Technologies dismissing the writ of certiorari previously granted to Laboratory Corporation of America Holdings d/b/a LabCorp in a homocysteine patent case.
The FDA and Cary, Ill.-based Sage Products June 23 announced a voluntary recall of lots of Comfort Shield Perineal Care washcloths shipped between Feb. 10 and May 19 to hospitals, medical centers
and long-term care facilities in the U.S. and Canada.
Orthopedic medical device maker Biomet Inc. became on Monday the second major company in its sector to announce a subpoena from the U.S. Department of Justice's antitrust division.
A panel of the 8th U.S. Circuit Court of Appeals has overturned a ruling in a Missouri case where the state legislature had sought to deny Medicaid coverage for some medical equipment to most low-income adults, according to reports.
Boston Scientific's Cardiac Rhythm Management (CRM) division and the FDA June 26 announced a recall of a specific subset of the firm's pacemakers, cardiac resynchronization pacemakers and implantable cardioverter-defibrillators (ICDs).
Managers at device and diagnostics manufacturing facilities can expect to bear the brunt of accountability for lapses in their quality systems (QS), a compliance official with the FDA's Center for Devices and Radiological Health (CDRH) said at a recent industry conference.